ESMO Virtual Advanced Course on Biomarkers for Precision Medicine 2021
![ESMO-Advanced-Course-Biomarkers-Precision-Medicine-2021-1000x250](/var/esmo/storage/images/media/esmo/meetings/2021/_advanced-courses/images/esmo-advanced-course-biomarkers-precision-medicine-2021-1000x250/8439089-1-eng-GB/esmo-advanced-course-biomarkers-precision-medicine-2021-1000x250.jpg)
- Start date
- 13 Sep 2021
- End date
- 14 Sep 2021
- Location
- Virtual, GMT +8
Learning objectives
- An increasing number of therapeutics that require biomarkers testing are available for clinical use or are in advanced phase of clinical development
- Different technologies can be used for biomarker testing depending on the nature of the biomarker and the availability of biological samples
- The increasing use of large panels for comprehensive genomic profiling raises issues on data interpretation that require a multidisciplinary approach
- Monitoring the molecular evolution of the disease might allow the identification of resistance mechanisms and the development of more effective therapeutic strategies
- The identification of germline variants requires the activation of genetic counselling programs for patients and their families
Accreditation
The programme of this virtual event has been accredited with 7 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Albrecht Stenzinger, Germany
- Daniel S. W. Tan, Singapore